Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Calabresi

Showing results (11-20 of 465) with videos related to

Pageof 47
Sort By:
Lancet (London, England)|April 9, 2013
Anti-interleukin-2 receptor alpha for multiple sclerosis?Shiv Saidha, Peter A Calabresi
Brain : a Journal of Neurology|October 18, 2013
The expanding spectrum of aetiologies causing retinal microcystic macular changePavan Bhargava, Peter A Calabresi
Neurology|June 17, 2016
Is my MS patient failing treatment?Helmut Butzkueven, Peter A Calabresi
The Lancet. Neurology|January 30, 2016
Phenytoin in acute optic neuritis: neuroprotective or not?Shiv Saidha, Peter A Calabresi
Neurology|November 9, 2014
Complex antibody profiling to predict clinical outcome in childhood ADSBernhard Hemmer, Peter A Calabresi
The Lancet. Neurology|October 5, 2013
Emerging injectable therapies for multiple sclerosisJiwon Oh, Peter A Calabresi
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2014
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: yesShiv Saidha, Peter A Calabresi
Seminars in Neurology|September 20, 2016
Multiple SclerosisNicoline Schiess, Peter A Calabresi
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2016
Metabolomics in multiple sclerosisPavan Bhargava, Peter A Calabresi
Cell|August 18, 2023
The calvaria stands alone: Unique aspects of the skull bone marrow-meninges borderSachin P Gadani, Peter A Calabresi
Pageof 47

Showing results (11-20 of 465) with videos related to

Sort By:
Pageof 47
Lancet (London, England)|April 9, 2013
Anti-interleukin-2 receptor alpha for multiple sclerosis?Shiv Saidha, Peter A Calabresi
Brain : a Journal of Neurology|October 18, 2013
The expanding spectrum of aetiologies causing retinal microcystic macular changePavan Bhargava, Peter A Calabresi
Neurology|June 17, 2016
Is my MS patient failing treatment?Helmut Butzkueven, Peter A Calabresi
The Lancet. Neurology|January 30, 2016
Phenytoin in acute optic neuritis: neuroprotective or not?Shiv Saidha, Peter A Calabresi
Neurology|November 9, 2014
Complex antibody profiling to predict clinical outcome in childhood ADSBernhard Hemmer, Peter A Calabresi
The Lancet. Neurology|October 5, 2013
Emerging injectable therapies for multiple sclerosisJiwon Oh, Peter A Calabresi
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2014
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: yesShiv Saidha, Peter A Calabresi
Seminars in Neurology|September 20, 2016
Multiple SclerosisNicoline Schiess, Peter A Calabresi
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2016
Metabolomics in multiple sclerosisPavan Bhargava, Peter A Calabresi
Cell|August 18, 2023
The calvaria stands alone: Unique aspects of the skull bone marrow-meninges borderSachin P Gadani, Peter A Calabresi
Pageof 47